Cipla Limited — Codeine Exporter Profile
Indian Pharmaceutical Exporter · #6 for Codeine · $1.4M export value · DGFT Verified
Cipla Limited is the #6 Indian exporter of Codeine with $1.4M in export value and 211 verified shipments. Cipla Limited holds a 1.6% market share in Codeine exports across 3 countries. The company exports 98 pharmaceutical products worth $1.1B across 26 therapeutic categories.
Cipla Limited — Codeine Export Profile: Buyers & Destinations
Where Does Cipla Limited Export Codeine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $1.2M | 192 | 84.9% |
| AUSTRALIA | $133.4K | 13 | 9.4% |
| YEMEN, DEMOCRATIC | $81.6K | 6 | 5.7% |
Cipla Limited exports Codeine to 3 countries. The largest destination is UNITED KINGDOM accounting for 84.9% of Cipla Limited's Codeine shipments, followed by AUSTRALIA (9.4%) and YEMEN, DEMOCRATIC (5.7%). These destinations reflect Cipla Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Codeine from Cipla Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ALLOGA UK LTD | UNITED KINGDOM | $1.2M | 186 |
| CIPLA AUSTRALIA PTY LTD, | AUSTRALIA | $108.3K | 10 |
| CIPLAMEDICA PHARMACEUTICAL INDUSTRI | YEMEN, DEMOCRATIC | $81.6K | 6 |
| ALLOGA UK LIMITED | UNITED KINGDOM | $22.4K | 6 |
| CIPLA AUSTRALIA PTY LIMITED | AUSTRALIA | $12.7K | 1 |
| ARROW PHARMACEUTICALS PTY LTD | AUSTRALIA | $8.9K | 1 |
| SIGMA CO,LTD ( ROWVILLE) SIGMA CO,L | AUSTRALIA | $3.6K | 1 |
Cipla Limited supplies Codeine to 7 buyers globally. The largest buyer is ALLOGA UK LTD (UNITED KINGDOM), followed by CIPLA AUSTRALIA PTY LTD, (AUSTRALIA) and CIPLAMEDICA PHARMACEUTICAL INDUSTRI (YEMEN, DEMOCRATIC). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Codeine Export Value and How Much Does Cipla Limited Contribute?
India exported $59.2M worth of Codeine through 1,785 shipments from 30 suppliers to 35 countries, serving 82 buyers globally. Cipla Limited contributes $1.4M to this total, accounting for 1.6% of India's Codeine exports. Cipla Limited ships Codeine to 3 countries through 7 buyers.
What Is the Average Shipment Value for Cipla Limited's Codeine Exports?
Cipla Limited's average Codeine shipment value is $6.7K per consignment, based on 211 shipments totaling $1.4M. The largest destination is UNITED KINGDOM (84.9% of Cipla Limited's Codeine exports).
How Does Cipla Limited Compare to Other Indian Codeine Exporters?
Cipla Limited ranks #6 among 30 Indian Codeine exporters with a 1.6% market share. The top 3 exporters are ADCOCK INGRAM LIMITED ($33.3M), WOCKHARDT LIMITED ($9.6M), MEDREICH LIMITED ($7.3M). Cipla Limited processed 211 shipments to 3 destination countries.
What Codeine Formulations Does Cipla Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CIPLA PAIN RELIEF PARACETAMOL + CODEINE | $92.3K | 8 |
| CO-CODAMOL 8/500MG EFFERVESCENT TABS (PARACETAMOL 500MG+CODEINE PHOSPHATE 8MG ) (INV QTY. 10800 PACK X 8 X 4 | $90.8K | 5 |
| CO-CODAMOL 30/500MG EFFERVESCENT TABS(PARACETAMOL 500MG+CODEINE PHOSPHATE 30MG ) (INV .QTY. 3423 PACK 10X10'S | $47.1K | 2 |
| CO-CODAMOL 30/500MG EFFERVESCENT TABS(PARACETAMOL 500MG+CODEINE PHOSPHATE 30MG ) INV.QTY. 3402 PACK 10X10'S=3 | $46.7K | 2 |
| CO-CODAMOL 8/500 MG EFFERVESCENT TABS PARACETAMOL 500 MG + CODEINE PHOSPHATE 8MGINV.QTY.10680 PACK 8X4S=341760 NOS | $44.7K | 4 |
| CO CODAMOL 8 500 MG EFFERVESCENT TABS PARACETAMOL 500 MG CODEINE PHOSPHATE 8MG INV QTY 10680 PACK 8X4S 341760 NOS | $43.1K | 4 |
| CO-CODAMOL 8/500MG EFFERVESCENT TABS (PARACETAMOL 500MG+CODEINE PHOSPHATE 8MG ) (INV QTY. 10800 PACK 8 X 4'S | $38.0K | 2 |
| CO-CODAMOL 8/500MG EFFERVESCENT TABS (PARACETAMOL 500MG+CODEINE PHOSPHATE 8MG ) (INV QTY.10860 PACK X8 X4'S=3 | $36.5K | 2 |
| CO-CODAMOL 8/500MG EFFERVESCENT TABS (PARACETAMOL 500MG+CODEINE PHOSPHATE 8MG ) (INV QTY. 10680 PACK X 8 X 4 | $35.9K | 2 |
| CO-CODAMOL 8/500MG EFFERVESCENT TABS (PARACETAMOL 500MG+CODEINE PHOSPHATE 8MG ) (INV QTY. 10860 PACK X 8 X 4 | $35.7K | 2 |
Cipla Limited exports 101 distinct Codeine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CIPLA PAIN RELIEF PARACETAMOL + CODEINE with 8 shipments worth $92.3K.
Regulatory Requirements: Exporting Codeine to Key Markets
What Cipla Limited must comply with to export Codeine to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Cipla Limited Compare to Nearest Codeine Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | MEDREICH LIMITED | $7.3M | 145 | 4 | $50.0K |
| 4 | SANOFI INDIA LIMITED | $3.8M | 75 | 2 | $50.0K |
| 6 | CIPLA LIMITED ★ | $1.4M | 211 | 3 | $6.7K |
| 5 | PRG PHARMA PRIVATE LIMITED | $750.0K | 15 | 2 | $50.0K |
| 7 | VENOR PHARMA LIMITED | $740.8K | 36 | 15 | $20.6K |
Cipla Limited ranks #6 among 30 Indian Codeine exporters. Average shipment value of $6.7K compared to the market average of $2.0M. The closest competitors by value are MEDREICH LIMITED and SANOFI INDIA LIMITED.
Which Indian Ports Ship Codeine Exports?
| Port | Shipments | % Share |
|---|---|---|
| BANGALORE ICD | 657 | 36.8% |
| BANGALORE ICD (INWFD6) | 205 | 11.5% |
| NHAVA SHEVA SEA (INNSA1) | 171 | 9.6% |
| JNPT/ NHAVA SHEVA SEA | 135 | 7.6% |
| JNPT | 114 | 6.4% |
| SAHAR AIR | 80 | 4.5% |
| Bangalore | 59 | 3.3% |
| Bangalore ICD | 34 | 1.9% |
Geopolitical & Trade Policy Impact on Cipla Limited's Codeine Exports
Cipla's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly acute for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management.
In the United States, recent import policies, including the imposition of 100% tariffs on branded or patented pharmaceutical products effective October 2025, have introduced additional hurdles for Indian exporters. While generic drugs, a significant component of Cipla's portfolio, may be less affected, the overall trade environment demands vigilance and adaptability. Conversely, the India-European Union Free Trade Agreement, concluded in January 2026, offers a promising avenue for Cipla. The agreement aims to eliminate tariffs on pharmaceuticals, potentially enhancing Cipla's competitiveness in the European market and offsetting challenges faced in other regions.
Cipla Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Cipla, given the diverse regulatory environments across its export markets. The company has demonstrated a strong commitment to compliance, as evidenced by the U.S. Food and Drug Administration's (FDA) classification of its Bengaluru facility as Voluntary Action Indicated (VAI) in October 2025. This classification is crucial for sustaining and expanding Cipla's presence in the U.S. market. Additionally, the European Union's evolving regulatory framework, including the Falsified Medicines Directive, necessitates continuous adaptation to ensure compliance and maintain market access.
About Cipla Limited
Cipla Limited exports 98 products worth $1.1B. Beyond Codeine, top products include Fluticasone, Amlodipine, Salbutamol, Telmisartan, Salmeterol. View the complete Cipla Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Codeine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Codeine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Cipla Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 211 individual customs records matching Cipla Limited exporting Codeine, covering 101 formulations to 3 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 35+ countries, 82+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Codeine Export Data from Cipla Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Cipla Limited's Codeine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Cipla Limited
Full Company Profile →
98 products · $1.1B total trade · 26 categories
Codeine Stats
Company Overview
Top Products by Cipla Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Cipla Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Codeine. For current shipment-level data, contact TransData Nexus.